A JOINT VENTURE BETWEEN ONYX EQUITIES AND MACHINE INVESTMENT GROUP ACQUIRES TWO MILLION SF BIOLOGICS RESEARCH AND DEVELOPMENT CAMPUS IN KENILWORTH, N.J., FROM MERCK SHARP & DOHME LLC WITH PLANS TO...

Merck to Continue as Tenant While New Headquarters Is Expanded.

NEWARK, N.J., Feb. 16, 2023 /PRNewswire/ -- A Joint Venture between Onyx Equities, LLC and Machine Investment Group, LLC ("the Venture") has acquired Merck Sharp & Dohme LLC ("Merck") former world headquarters, which features nearly two million square feet of biologics, research, and development buildings on its 108-acre campus in Kenilworth, New Jersey. This closing represents one of the largest New Jersey office and life sciences transactions in history.

The Venture will market the site's state-of-the-art laboratories and support facilities to biotechnology, pharmaceutical, and technology companies that value a highly educated life sciences labor pool and proximity to regional infrastructure and thoroughfares. Merck will lease back the entirety of the historic site, vacating in phases over the next several years.

"New Jersey receives two forms of good news today as one of the pillars of our business community chooses to commit its long-term future to New Jersey and one of our leading developers prepares to build a high-tech life sciences hub, consistent with our vision for New Jersey's economic future," said New Jersey Governor Phil Murphy. "I congratulate both Merck and Onyx and eagerly await the advancements they will make in our state, which will solidify our status as a national leader in the life sciences sector."

"This collaboration is an incredible opportunity to help reimagine the hub of life sciences while also continuing Merck's strong history and legacy of serving patients and communities," said Shefali Shah, Global Real Estate Lead, Merck. "We believe Onyx Equities, LLC will foster long-term value, economic growth and sustainability within the community. We look forward to collaborating with Onyx Equities, LLC and their team members on a smooth transition."

"The life sciences industry is surging, and its rapidly developing technology requires new specialty facilities," said John Saraceno, Jr., Co-Founder and Managing Principal for Onyx Equities, LLC. "The Merck campus represents an opportunity to host blue chip companies that will benefit from proximity to New Jersey and New York's highly educated workforce. We're excited to apply Onyx's unique asset repositioning platform to attract the next generation of life science and technology leaders."

In addition to over 1.4 million square feet of laboratories, the campus features 500,000 square feet of Class-A professional office space, 30 acres of developable land, a 25-megawatt cogeneration plant, three full-service cafeterias, a fitness center, auditoriums and conference centers, outdoor amenity areas, and over 3,200 surface and structured parking spaces.

The property sits at a direct interchange off the Garden State Parkway at Exit 138 in a premier location. In addition to direct access to the Garden State Parkway, the property enjoys proximity to Route 78, the Route 22 retail corridor, the New Jersey Turnpike, Newark Liberty International Airport, and the Port Newark Elizabeth Marine Terminal.

Merck was represented in the transaction by Dan Loughlin, Jose Cruz, and Kevin O'Hearn of New Jersey's JLL office. Onyx's development team handled the transaction internally. 

About Onyx Equities, LLC

Headquartered in Woodbridge, New Jersey, Onyx Equities, LLC is a leading, full-service real estate firm specializing in investment, asset repositioning and ground-up development. Since its founding in 2004, Onyx has acquired more than $2.3B worth of real estate assets throughout New Jersey, New York, Pennsylvania, and Connecticut, and has executed over $350M in capital improvement projects under its signature repositioning program. Driving Onyx's success is its deep understanding of the development process and core geographic markets, a seasoned team of expertise in all facets of real estate, and its adaptability to market conditions and the experience gained from managing over 65 MSF since inception. Throughout its esteemed portfolio of properties, Onyx takes aim at increasing operational efficiency, tenant satisfaction and long-term value to create dynamic commercial, residential and mixed-use environments of the highest quality. For more information about Onyx Equities, visit www.OnyxEquities.com.

About Machine Investment Group

Machine Investment Group is a real estate investment firm focused on opportunistic, distressed, and special situations across the United States. Founded in 2020 by Eric Rosenthal and Andy Kwon, Machine invests primarily in the middle market, where its reputation as a reliable counterparty, its solutions-oriented approach and extensive lender relationships support proprietary deal flow. Machine's strict risk discipline, institutional operating processes and well-developed sourcing network has been cycle-tested and is designed to deliver consistent, opportunistic returns while minimizing losses.

View original content:https://www.prnewswire.com/news-releases/a-joint-venture-between-onyx-equities-and-machine-investment-group-acquires-two-million-sf-biologics-research-and-development-campus-in-kenilworth-nj-from-merck-sharp--dohme-llc-with-plans-to-continue-sites-current-use-301749366.html

SOURCE Onyx Equities